|
|
|
Insider
Information: |
Fisherman Jason S |
Relationship: |
Director |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
27,946 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$172,830 |
|
|
Total
Shares |
27,946 |
|
|
Total
Value |
$172,830 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Exelixis Inc |
EXEL |
See Footnote Below |
2003-09-05 |
0 |
2005-09-08 |
7,881 |
Premium* |
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
|
0 |
2004-03-25 |
12,204 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
|
2020-01-28 |
0 |
2020-01-28 |
0 |
Premium* |
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
Director |
2010-10-27 |
0 |
2010-10-27 |
7,861 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2006-10-31 |
4 |
A |
$0.00 |
$0 |
I/I |
1,115 |
1,115 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Director |
|
2010-10-27 |
4 |
A |
$0.00 |
$17,374 |
I/I |
7,096 |
7,109 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2017-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,500 |
1,500 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Director |
|
2010-10-27 |
4 |
B |
$9.50 |
$7,021 |
I/I |
739 |
7,848 |
2.1 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2013-06-03 |
4 |
B |
$7.87 |
$78,700 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2013-06-21 |
4 |
B |
$7.63 |
$76,300 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2013-08-14 |
4 |
B |
$6.83 |
$34,150 |
D/D |
5,000 |
25,000 |
2.39 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2013-11-18 |
4 |
B |
$2.67 |
$26,700 |
D/D |
10,000 |
35,000 |
2.39 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2013-11-19 |
4 |
B |
$2.56 |
$12,800 |
D/D |
5,000 |
40,000 |
2.39 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2016-12-22 |
4 |
B |
$3.96 |
$39,600 |
D/D |
10,000 |
50,000 |
2.39 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-09-05 |
4 |
D |
$7.54 |
$1,908 |
I/I |
(253) |
10,179 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-12-02 |
4 |
D |
$6.90 |
$1,698 |
I/I |
(246) |
9,933 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-12-03 |
4 |
D |
$6.89 |
$3,059 |
I/I |
(444) |
9,489 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2003-12-05 |
4 |
D |
$6.80 |
$41 |
I/I |
(6) |
9,483 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2004-03-01 |
4 |
D |
$9.20 |
$451 |
I/I |
(49) |
9,434 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2004-03-04 |
4 |
D |
$9.20 |
$1,132 |
I/I |
(123) |
9,311 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2004-03-05 |
4 |
D |
$9.36 |
$4,155 |
I/I |
(444) |
8,867 |
|
- |
|
ACHN |
Achillion Pharmaceuticals... |
|
|
2020-01-28 |
4 |
D |
$6.30 |
$567,000 |
D/D |
(90,000) |
0 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
|
|
2020-01-28 |
4 |
D |
$6.30 |
$9,450 |
I/I |
(1,500) |
0 |
0 |
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2004-03-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,204 |
|
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Director |
|
2010-10-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
13 |
|
- |
|
ACHN |
Achillion Pharmaceuticals... |
Director |
|
2018-06-06 |
4 |
OE |
$1.05 |
$21,000 |
D/D |
20,000 |
70,000 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
|
|
2019-11-14 |
4 |
OE |
$3.28 |
$65,600 |
D/D |
20,000 |
90,000 |
0 |
- |
|
EXEL |
Exelixis Inc |
Director |
|
2005-09-07 |
4 |
S |
$7.87 |
$968 |
I/I |
(123) |
8,744 |
|
- |
|
EXEL |
Exelixis Inc |
Director |
|
2005-09-08 |
4 |
S |
$7.87 |
$6,790 |
I/I |
(863) |
7,881 |
|
- |
|
36 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|